[1] Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK [J]. Proc Natl Acad Sci USA, 1998, 95(22): 13221-13226. [2] Huang YC, Hung WC, Chen WT, et al. Effects of DNMT and MEK inhibitors on the expression of RECK, MMP-9, -2, uPA and VEGF in response to arsenite stimulation in human uroepithelial cells [J]. Toxicol Lett, 2011, 201(1): 62-71. [3] Takenaka K, Ishikawa S, Kawano Y, et al. Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer [J]. Eur J Cancer, 2004, 40(10): 1617-1623. [4] Takeuchi T, Hisanaga M, Nagao M, et al. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer [J]. Clin Cancer Res, 2004, 10(16): 5572-5579. [5] Song SY, Son HJ, Nam E, et al. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer[J]. Eur J Cancer,2006,42(1): 101-108. [6] Das PM, Singal R. DNA methylation and cancer [J]. J Clin Oncol, 2004, 22(22): 4632-4642. [7] Hellebrekers DM, Griffioen AW, van Engeland M. Dual targeting of epigenetic therapy in cancer [J]. Biochim Biophys Acta, 2007, 1775(1): 76-91. [8] Shaw RJ, Hall GL, Lowe D, et al. CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology [J]. Oral Oncol, 2007, 43(9): 878-886. [9] Kato K, Long NK, Makita H, et al. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells [J]. Br J Cancer, 2008, 99(4): 647-654. |